[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-342944-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-342944-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","application-of-graph-models-to-the-identification-of-transcriptomic-oncometabolic-pathways-in-human-hepatocellular-carcinoma","Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma","","Whole-tissue transcriptomic analyses support the identification of molecular subtypes in hepatocellular carcinoma (HCC), but metabolic classes may not reflect clinically actionable cancer vulnerabilities. Publicly available gene sets are commonly used with gene set enrichment or variation methods; however, metabolism-related signatures often show poor co-expression in biological contexts. This work applies graph-based statistics to infer highly consistent metabolic signatures, defining metabolic clusters and linking them to molecular classes and TP53/CTNNB1 driver mutations. Validation and pathway analyses highlight N-glycan, mevalonate, and sphingolipid biosynthesis as key oncogenic shifts.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/application-of-graph-models-to-the-identification-of-transcriptomic-oncometabolic-pathways-in-human-hepatocellular-carcinoma/342944/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/application-of-graph-models-to-the-identification-of-transcriptomic-oncometabolic-pathways-in-human-hepatocellular-carcinoma/342944.png","ImageObject",300,407,{"name":42,"@type":43},"Aria","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the study address with existing metabolic gene signatures in HCC?","Question",{"text":63,"@type":64},"Metabolism-related gene signatures can show poor co-expression in biological contexts, limiting how well they capture functional changes in transcriptomic analyses.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does the study infer more consistent metabolic signatures?",{"text":68,"@type":64},"It applies graph-based statistics to derive highly consistent signatures rather than relying solely on traditional gene set enrichment approaches.",{"name":70,"@type":61,"acceptedAnswer":71},"Which biological pathways are identified as hallmark features of the oncogenic shift in HCC metabolism?",{"text":72,"@type":64},"N-glycan, mevalonate, and sphingolipid biosynthetic pathways are reported as the hallmark of the oncogenic metabolic shift.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},342944,1790791167,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":127,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},2336464648322,"https://ap-avatar.wpscdn.com/avatar/2200025388227c56fec?_k=1778556882303663488","biomolecules  \nArticle  \nApplication of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma  \nSergio Barace 1, Eva Santamaría 1,2, Stefany Infante 1,3, Sara Arcelus 1, Jesus De La Fuente 4, Enrique Goñi 4, Ibon Tamayo 4, Idoia Ochoa 5, Miguel Sogbe 6, Bruno Sangro 2,6,7, Mikel Hernaez 4,7,†, Matias A. Avila 2,7,8,† and Josepmaria Argemi 1,2,6,7,9, *,†  \nCitation: Barace, S.; Santamaría, E.; Infante, S.; Arcelus, S.; De La Fuente, J.; Goñi, E.; Tamayo, I.; Ochoa, I.; Sogbe, M.; Sangro, B.; et al. Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma. Biomolecules 2024, 14, 653. [https://](https://)[ ](https://)[doi.org/10.3390/biom14060653](doi.org/10.3390/biom14060653)  \nAcademic Editor: Dirk Geerts  \nReceived: 29 April 2024  \nRevised: 22 May 2024  \nAccepted: 29 May 2024  \nPublished: 3 June 2024  \nCopyright: © 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ([https://](https://)[ ](https://)[creativecommons.org/licenses/by/](creativecommons.org/licenses/by/)[ ](creativecommons.org/licenses/by/)[4.0/](4.0/)) .  \n1 DNA and RNA Medicine Division, Applied Medical Research Center (CIMA), University of Navarre, 31008 Pamplona, Spain; [sbarace@alumni.unav.es](sbarace@alumni.unav.es) (S.B.); [evasmaria@external.unav.es](evasmaria@external.unav.es) (E.S.); [stefany.infante@udep.edu.pe](stefany.infante@udep.edu.pe) (S.I.); [sarcelus@unav.es](sarcelus@unav.es) (S.A.)  \n2 Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBER-EHD), Av. Monforte de Lemos, 3-5. Pabellón 11, Planta 0, 28029 Madrid, Spain; [maavila@unav.es](maavila@unav.es) (M.A.A.)  \n3 Facultad de Medicina Humana, Universidad de Piura, Lima 15074, Peru  \n4 Bioinformatics Platform, Applied Medical Research Center (CIMA), University of Navarre,  \n31008 Pamplona, Spain; [mhernaez@unav.es](mhernaez@unav.es) (M.H.)  \n5 Tecnun School of Engineering (TECNUN), University of Navarre, 31008 Pamplona, Spain; [iochoal@unav.es](iochoal@unav.es)  \n6 Liver Unit, Tecnun School of Engineering (TECNUN), University of Navarre, 31008 Pamplona, Spain; [msogbe@unav.es](msogbe@unav.es)  \n7 Instituto de Investigación Sanitaria de Navarra (IdisNA), 31008 Pamplona, Spain  \n8 Solid Tumor Program, Hepatology Laboratory, Applied Medical Research Center (CIMA), University of Navarre, C. de Irunlarrea, 3, 31008 Pamplona, Spain  \n9 Division of Gastroenterology Hepatology and Nutrition, University of Pittsburgh, Pittsburgh, PA 15232, USA  \n* Correspondence: jargemi@unav.es † These authors contributed equally to this work.  \nAbstract: Whole-tissue transcriptomic analyses have been helpful to characterize molecular subtypes of hepatocellular carcinoma (HCC) . Metabolic subtypes of human HCC have been defined, yet whether these different metabolic classes are clinically relevant or derive in actionable cancer vulnerabilities is still an unanswered question. Publicly available gene sets or gene signatures have been used to infer functional changes through gene set enrichment methods. However, metabolism-related gene signatures are poorly co-expressed when applied to a biological context. Here, we apply a simple method to infer highly consistent signatures using graph-based statistics. Using the Cancer Genome Atlas Liver Hepatocellular cohort (LIHC), we describe the main metabolic clusters and their relationship with commonly used molecular classes, and with the presence of TP53 or CTNNB1 driver mutations. We find similar results in our validation cohort, the LIRI-JP cohort. We describe how previously described metabolic subtypes could not have therapeutic relevance due to their overall downregulation when compared to non-tumoral liver, and identify N-glycan, mevalonate and sphingolipid biosynthetic pathways as the","cbCaiaxlw5jCkbO0","https://ap.wps.com/l/cbCaiaxlw5jCkbO0","pdf",5543602,"English","# Introduction\n## Gene set enrichment and signature challenges\n# Abstract\n## Oncometabolic clusters and validation\n# Methods (from context)\n## Graph-based statistics for signature consistency\n# Results (from context)\n## Metabolic clusters, driver mutations, and oncogenic pathway shifts","[{\"question\":\"What problem does the study address with existing metabolic gene signatures in HCC?\",\"answer\":\"Metabolism-related gene signatures can show poor co-expression in biological contexts, limiting how well they capture functional changes in transcriptomic analyses.\"},{\"question\":\"How does the study infer more consistent metabolic signatures?\",\"answer\":\"It applies graph-based statistics to derive highly consistent signatures rather than relying solely on traditional gene set enrichment approaches.\"},{\"question\":\"Which biological pathways are identified as hallmark features of the oncogenic shift in HCC metabolism?\",\"answer\":\"N-glycan, mevalonate, and sphingolipid biosynthetic pathways are reported as the hallmark of the oncogenic metabolic shift.\"}]","Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma | PDF",1790048998,48,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f426c6d89dc5af7c942d399c74903a37.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7536e83fed031b9a199ee5085b31794c.webp",982,1388,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c2b6436f7ddeec5c4def67c12b39937f.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e884ff585f0deeff44a50de457c67eac.webp",980,1385]